ミラースピーチのエントレインメント：非流動性失語症の音声パーソナライズされた音声エントレインメントのための新しい手法 (MSE)
The goal of this clinical trial is to test the use of voice personalization through artificial intelligence (AI) voice cloning on speech entrainment tasks to improve language production of persons with aphasia (PWA). The main question the study aims to answer is:
- What is the impact of personalized voice on speech entrainment in PWA compared to traditional speech entrainment?
Speech entrainment is a technique used by speech-language pathologists to improve the speech production of PWA. Traditionally, speech therapists act as the model for participants to speak along with to improve their speech production. This study proposes the use of one's own voice (digitally altered) to improve speech production.
The study uses a mobile health approach to administer speech entrainment treatment through a mobile app.
- Smartphones with the mobile app pre-installed will be mailed to participants at no cost.
- Participants will complete treatment in the comfort of their homes.
- The experimental treatments involve: mirror speech entrainment (speaking along to one's own voice) and traditional speech entrainment (speaking along to someone else's voice).
調査の概要
状態
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Florida
-
Tampa、Florida、アメリカ、33612
- University of South Florida
-
Tampa、Florida、アメリカ、33614
- University of South Florida
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Adults between the ages of 18-70 years old
- Dominant English-speaking
- Aphasia due to left hemisphere stroke
Exclusion Criteria:
- Individuals with aphasia due to other causes such as dementia, Alzheimer's disease and Parkinsonism
- Non-dominant English adult speakers
- Persons with significant difficulties with language comprehension
- Persons with concomitant cognitive disability
- Persons with uncorrected sensory deficits.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Experiment 1: Feasibility Study
Participants will receive two treatments sequentially: mirror speech entrainment using the auditory-only modality followed by mirror speech entrainment using the auditory-visual modality. |
Speech entrainment with the user's own voice using auditory-only and auditory-visual modalities. |
|
実験的：Experiment 2: Mirror SE versus Traditional SE (Auditory-only)
This arm investigates the use of mirror speech entrainment using auditory only feedback and traditional speech entrainment using auditory only feedback. |
Speech entrainment with the user's own voice using auditory-only and auditory-visual modalities. Traditional speech entrainment (speech entrainment using an external agent's voice) using the auditory-only modality (users only listen and speak along to auditory stimuli) |
|
実験的：Experiment 3: Mirror SE versus Traditional SE (Auditory-visual)
This arm will investigate the effect of mirror speech entrainment in the auditory-visual modality versus traditional speech entrainment in the auditory-visual modality. |
Speech entrainment with the user's own voice using auditory-only and auditory-visual modalities. Traditional speech entrainment (speech entrainment using an external agent's voice) using the auditory-visual modality (users listen and speak along to both auditory and visual stimuli (mouth movements) |
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Speaking rate
時間枠：From enrollment to the end of treatment at 6 weeks
|
Language production as assessed by number of correct words produced per minute |
From enrollment to the end of treatment at 6 weeks
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 007481
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data will only be shared with approved members of the research team.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。